Perspective Therapeutics (AMEX: CATX) 10% owner Lantheus Alpha Therapy sold 113,914 shares across two transactions at $3.12 to $3.14 per share. The owner retained 11,563,425 Perspective Therapeutics shares afterward, giving investors the reported post-transaction ownership figure alongside the sale details.
Key Highlights
- The transactions took place between August 31 and September 1, 2026.
- Lantheus Alpha Therapy owned 11,563,425 Perspective Therapeutics shares after the sales.
- Lantheus Alpha Therapy also sold 42,129 Lantheus Holdings shares at $3.11 per share.
Perspective Therapeutics, Inc. (AMEX: CATX) 10% owner Lantheus Alpha Therapy, LLC sold 113,914 shares at prices ranging from $3.12 to $3.14 per share. The sales occurred across two transactions between August 31 and September 1, 2026.
Two Transactions Cover 113,914 Shares The
sales used transaction code S and were completed over the two dates identified in the ownership report. Lantheus Alpha Therapy retained 11,563,425 Perspective Therapeutics shares after the transactions. The reported ownership figure follows the sale activity. Lantheus Alpha Therapy also sold 42,129 shares of Lantheus Holdings, Inc (NASDAQ: LNTH). at $3.11 per share. That transaction concerns Lantheus Holdings rather than Perspective Therapeutics.
FAQs
Q: How many Perspective Therapeutics shares did Lantheus Alpha Therapy sell?
A: Lantheus Alpha Therapy sold 113,914 Perspective Therapeutics shares. The sales were completed across two transactions at prices ranging from $3.12 to $3.14 per share.
Q: How many Perspective Therapeutics shares did Lantheus Alpha Therapy retain?
A: Lantheus Alpha Therapy retained 11,563,425 Perspective Therapeutics shares after the reported sales. This figure represents its post-sale ownership balance following transactions completed between August 31 and September 1, 2026.
Q: When did the Perspective Therapeutics share sales occur?
A: The transactions took place between August 31 and September 1, 2026. The reported sale prices ranged from $3.12 to $3.14 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.